| Ms Stephanie A Farmer, APN | |
|
319 Bryant Ave, Suite 1, Bryant, AR 72022-3815 | |
| (501) 653-0353 | |
| (501) 653-0347 |
| Full Name | Ms Stephanie A Farmer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 19 Years |
| Location | 319 Bryant Ave, Bryant, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518982305 | NPI | - | NPPES |
| 190503758 | Medicaid | AR | |
| 5AG98 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A01943 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saline Memorial Hospital | Benton, AR | Hospital |
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saline Clinics Llc | 0547553836 | 25 |
News Archive
A trial in Zimbabwe has shown that a programme of integrated peer education, condom distribution, and management of sexually transmitted infections did not reduce the overall incidence of HIV-1.
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced that the company has received Certificates of Registration from the United States Patent and Trademark Office for its SYMPHONY and PRELUDE trademarks, as used with Echo's tCGM system and mechanical skin ablator, respectively.
A University of Arizona doctoral candidate has shown for the first time that genetic mutations in the titin gene can cause skeletal muscle myopathy, a disease in which muscle fibers do not function properly, resulting in muscle weakness.
Genetically diverse bacterial strains that cause urinary tract infections differ in their ability to trigger protective immune responses in mice, potentially explaining why these infections frequently recur in many patients, according to a study published December 13 in the open-access journal PLOS Pathogens by Thomas Hannan and Scott Hultgren of Washington University School of Medicine, and colleagues.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.
› Verified 7 days ago
| Entity Name | Saline Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447609367 PECOS PAC ID: 0547553836 Enrollment ID: O20160725001118 |
News Archive
A trial in Zimbabwe has shown that a programme of integrated peer education, condom distribution, and management of sexually transmitted infections did not reduce the overall incidence of HIV-1.
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced that the company has received Certificates of Registration from the United States Patent and Trademark Office for its SYMPHONY and PRELUDE trademarks, as used with Echo's tCGM system and mechanical skin ablator, respectively.
A University of Arizona doctoral candidate has shown for the first time that genetic mutations in the titin gene can cause skeletal muscle myopathy, a disease in which muscle fibers do not function properly, resulting in muscle weakness.
Genetically diverse bacterial strains that cause urinary tract infections differ in their ability to trigger protective immune responses in mice, potentially explaining why these infections frequently recur in many patients, according to a study published December 13 in the open-access journal PLOS Pathogens by Thomas Hannan and Scott Hultgren of Washington University School of Medicine, and colleagues.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Stephanie A Farmer, APN Po Box 1615, Searcy, AR 72145-1615 Ph: (501) 776-6019 | Ms Stephanie A Farmer, APN 319 Bryant Ave, Suite 1, Bryant, AR 72022-3815 Ph: (501) 653-0353 |
News Archive
A trial in Zimbabwe has shown that a programme of integrated peer education, condom distribution, and management of sexually transmitted infections did not reduce the overall incidence of HIV-1.
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced that the company has received Certificates of Registration from the United States Patent and Trademark Office for its SYMPHONY and PRELUDE trademarks, as used with Echo's tCGM system and mechanical skin ablator, respectively.
A University of Arizona doctoral candidate has shown for the first time that genetic mutations in the titin gene can cause skeletal muscle myopathy, a disease in which muscle fibers do not function properly, resulting in muscle weakness.
Genetically diverse bacterial strains that cause urinary tract infections differ in their ability to trigger protective immune responses in mice, potentially explaining why these infections frequently recur in many patients, according to a study published December 13 in the open-access journal PLOS Pathogens by Thomas Hannan and Scott Hultgren of Washington University School of Medicine, and colleagues.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.
› Verified 7 days ago
Chelsea Elizabeth Griffith, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4411 Highway 5 N, Bryant, AR 72022 Phone: 501-847-0289 | |
Mrs. Floye L Taylor, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 408 Office Park Dr Ste 3, Bryant, AR 72022 Phone: 501-847-2835 Fax: 501-847-3802 | |
Lynn Shaw, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3345 Hwy 5 N Ste 300, Bryant, AR 72019 Phone: 501-521-1100 | |
Brittani Moffett, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2301 Springhill Rd Ste 200, Bryant, AR 72019 Phone: 501-847-2500 Fax: 501-943-3016 | |
Teryn N Lane, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3345 Highway 5 N Ste 300, Bryant, AR 72019 Phone: 501-521-1100 | |
Sharon Mcdaniel, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 408 Office Park Dr Ste 2, Bryant, AR 72022 Phone: 501-539-6836 | |
Heather Diane Abernathy, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1501 Aspen Acres Dr, Bryant, AR 72019 Phone: 501-844-1983 |